Let's have a look at a few earnings reports from earlier in the week. We'll check out two businesses operating in the arena of consumer products -- Colgate-Palmolive (CL) and Procter & Gamble (PG) -- and one that is prospering from a crimson DVD-rental kiosk that has become all the rage -- Coinstar (CSTR).

We'll start with the latter concern first. Coinstar was one of Friday's great stock stories. It shot higher by 16%, backed by an incredible amount of volume. Investors are apparently counting on this one to go even higher. In fact, some analysts believe that the shares may eventually reach $60.

Analyst Upgrades

• JPMorgan upgraded T. Rowe Price (TROW) to overweight from neutral while downgrading Janus Capital (JNS) to underweight from neutral to reflect valuations and fundamentals. The firm has a $67 price target for T. Rowe Price shares.
• Piper Jaffray upgraded Lincoln Electric (LECO) to overweight from neutral as it believes the rebound in global manufacturing is accelerating. The firm has a $70 price target on the stock.
• Wells Fargo upgraded Highwoods Properties (HIW) to market perform from underperform, citing valuation and a strong balance sheet.
• Corning (GLW) was upgraded to outperform from sector perform at RBC Capital.
• Allergan (AGN) was upgraded to conviction buy from neutral at Goldman.
• Mohawk (MHK) was upgraded to buy from neutral at SunTrust.

Consider this: Just 7% of all Indians brush their teeth at least once a day. If you're thinking about personal hygiene, you're probably grossed out.

But if you're thinking about global investing you're seeing dollar signs. It means more than a billion Indians haven't yet begun a daily ritual that is already commonplace around the world!

Here are some highlights from this past week's earnings coverage on BloggingStocks:

• Advanced Micro Devices Inc. (AMD) shares declined despite an earnings beat and a positive outlook
• Bank of America Corp. (BAC) reported that its Q4 loss widened more than expected by Wall Street.
• Capital One Financial Corp. (COF) reported better-than-expected earnings but shares declined.
• Colgate-Palmolive Co. (CL) is seen as on-track to record double-digit earnings growth in 2010.
• Cree Inc. (CREE) strong earnings and revenue growth sent shares to a new 52-week high.

Looking for dividend-paying blue chip stocks? Chuck Carlson is a leading expert on dividend reinvestment plans.

In The DRIP Investor, he looks at the 10/10 Club -- stocks that have boosted their payouts by 10% a year for at least 10 years. He explains,"The table below features seven stocks that belong to the exclusive '10/10' club:

I'm going defensive this year. The stock market had a great run in 2009 with the Dow Jones Industrial Average and the S&P 500 index up more than 60%. It's hard to believe stocks can run too much higher. They can, of course, if earnings explode. But that seems like a drug-induced dream at this point, considering over 10% unemployment.

I also think interest rates will be higher next year, that the economy will improve somewhat, and that unemployment will go down but not by much. So I'm focusing on stock with these attributes:

Yesterday I started a review of 25 companies that Fortune deemed most successful according to their peers in developing quality leadership. Today I review the remaining 20, searching to find the ones that might be worth investing in.

Price-to-book (from 11/27/09) was used as the first value screen. The theory being from a value investor's perspective that buying for a price at or near the break-up value of the company provides downside protection. Of course that is easier said than done.

The recent issue of Fortune magazine discusses how the best of the best train, guide and nurture top managers to become the leaders that will propel their corporations successfully forward. They list the top 25 companies, which I have used as the basis of a new review to see how they would fair against common metric screens.

In the past few months, many articles have posited that large-cap stocks should excel in the coming year based on their lagging the market behind smaller, more volatile stocks flying out of the March lows. I do not believe this is universally true. Plenty of large-cap stocks did well, such as Anadarko Petroleum (APC), Apple (AAPL) and Google (GOOG), while many small caps went nowhere. Even among the large caps included in Fortune's "Leadership 25," some have doubled.

The rest of the world is going to help U.S. consumer product manufacturers next year. Look for international growth to push the likes of Colgate-Palmolive (CL), Avon (AVP) and Clorox (CLX) higher in 2010, according to Fitch Ratings. In an interview with Reuters, a director gave the Fitch's outlook for consumer goods.

The household and personal care segments increased revenue every year from 2003 to 2008. So, 2009 was but a bump in the road. Even in a recession, you need toilet paper and shampoo, so expect the spending to come back.

"One way to build an inflation hedge into your investment cash flows is to focus on stocks that are likely to boost their dividends on a regular basis," explains dividend specialist Chuck Carlson.

In his The DRIP Investor, which focuses on blue chip companies offering dividend reinvestment programs, he notes, "Since dividends are paid with cold cash, they can't be faked. Either you pay the dividend or you don't. They can't be some figment of accounting magic." Here, he looks at three favorite blue chips with strong dividend records.

Clorox (NYSE: CLX), a consumer-products business that counts Procter & Gamble (NYSE: PG) and Colgate-Palmolive (NYSE: CL) as related stocks, may have seen a sales drop of 1% in its fiscal first quarter, but that didn't stop it from posting a nice bottom-line growth rate. Clorox made $1.11 per share in Q1, and that represents a 23% increase. What a way to start a new corporate year!

According to Reuters, expectations were for 95 cents per share. That's a wonderful beat. Plus, sales volume went up 1%. Helping to drive things along was a healthy gross margin, as well as the dreaded H1N1 virus. Clorox has done well over the years associating its brand with sanitizing effectiveness, so when a pandemic rears its ugly head, the trademark is prepared to leverage such reputation to drive value.